Apolipoproteins in the brain: implications for neurological and psychiatric disorders. - Wikidata - thesis-toulmin - TriplyDB

Apolipoproteins in the brain: implications for neurological and psychiatric disorders.

Apolipoproteins in the brain: implications for neurological and psychiatric disorders.

http://www.wikidata.org/entity/Q34680878

about

ApoD mediates binding of HDL to LDL and to growing T24 carcinoma Phospholipid transfer protein is expressed in cerebrovascular endothelial cells and involved in high density lipoprotein biogenesis and remodeling at the blood-brain barrier Preferential interactions between ApoE-containing lipoproteins and Aβ revealed by a detection method that combines size exclusion chromatography with non-reducing gel-shift Variations in apolipoprotein D and sigma non-opioid intracellular receptor 1 genes with relation to risk, severity and outcome of ischemic stroke.Two Alzheimer's disease risk genes increase entorhinal cortex volume in young adults Bipolar disorder with comorbid binge eating history: a genome-wide association study implicates APOB.A gene-brain-cognition pathway for the effect of an Alzheimer׳s risk gene on working memory in young adults.A combined effect of two Alzheimer's risk genes on medial temporal activity during executive attention in young adults.Differential Effects of apoE4 and Activation of ABCA1 on Brain and Plasma Lipoproteins.Apolipoprotein C-I is an APOE genotype-dependent suppressor of glial activation Potential biomarkers in psychiatry: focus on the cholesterol system.Apolipoprotein D takes center stage in the stress response of the aging and degenerative brain.ApoA-I/HDL Generation and Intracellular Cholesterol Transport through Cytosolic Lipid-Protein Particles in Astrocytes.Role of Apolipoproteins and α-Synuclein in Parkinson's Disease.The CLU-files: disentanglement of a mystery.Increased expression of ApoA1 after neuronal injury may be beneficial for healing.Central Nervous System Lipoproteins: ApoE and Regulation of Cholesterol Metabolism.Parallel changes in serum proteins and diffusion tensor imaging in methamphetamine-associated psychosis.Binding and repressive activities of apolipoprotein E3 and E4 isoforms on the human ApoD promoter.Memory Resilience to Alzheimer's Genetic Risk: Sex Effects in Predictor Profiles.What are lipoproteins doing in the brain?Blood-Brain Barriers in Obesity.Age-related neurodegenerative disease associated pathways identified in retinal and vitreous proteome from human glaucoma eyes.Proteomic characterization of pediatric craniopharyngioma intracystic fluid by LC-MS top-down/bottom-up integrated approaches.Restoring polyamines protects from age-induced memory impairment in an autophagy-dependent manner.The Glia-Neuron Lactate Shuttle and Elevated ROS Promote Lipid Synthesis in Neurons and Lipid Droplet Accumulation in Glia via APOE/D.Oleanolic Acid Inhibiting the Differentiation of Neural Stem Cells into Astrocyte by Down-Regulating JAK/STAT Signaling Pathway.Prenatal high-fat diet alters the cerebrovasculature and clearance of β-amyloid in adult offspring.Altered apolipoprotein C expression in association with cognition impairments and hippocampus volume in schizophrenia and bipolar disorder.Apolipoprotein D Overexpression Protects Against Kainate-Induced Neurotoxicity in Mice.The serine protease HtrA1 contributes to the formation of an extracellular 25-kDa apolipoprotein E fragment that stimulates neuritogenesis.Evaluation of Serum Apolipoprotein E as a Potential Biomarker for Pharmacological Therapeutic Efficacy Monitoring in Dopamine Dictated Disease Spectrum of Schizophrenia and Parkinson's disease: A Preliminary Study Orthologous proteins of experimental de- and remyelination are differentially regulated in the CSF proteome of multiple sclerosis subtypes

P2860

Q21559441-0FD3E2C6-923D-417C-A5E9-2E660DF81B94 Q24316276-84CECA6F-2F45-4816-9E72-C5EFFB242E5F Q28582464-EA954EC2-C232-45FE-AB13-3E8AB3C2902E Q34291875-EAEA0327-30E3-44E0-9640-3A1B73FDA58C Q34292129-776F66B4-E490-48F9-9A2D-078353077546 Q34471534-F4B33F2E-E45E-4EC6-B6FD-9602B7FAD03A Q35111848-DA331E32-6B7C-4753-8D2F-A1A625F84EEB Q35570776-E5210F3C-5F80-4B47-9F22-BE591EB10979 Q36185793-E32DC064-8A1F-4922-8338-0191635F90AE Q36376727-B64A195E-875C-4844-A36D-D7A9A1ED8B1A Q37981261-6AEC1C06-5D4B-462B-A453-280C291FC674 Q38194683-636C7B33-74DA-4645-8671-5A80E6356F11 Q38246791-6CED8C69-5FAE-44C3-AE17-D48ACAD83C39 Q38659590-F1B53DEE-4599-496C-86AB-CB4B2BB625C0 Q38670777-20C18DB9-CE3B-4799-8718-0C3B2685F7C0 Q38741473-4E559A2B-0C04-4FEA-9F8E-50038D4142A5 Q38833309-AE8F6832-C927-4B53-8D30-DFB1ECEDAF3B Q38933936-F0B235BB-8188-4909-8EB1-6BE3660CEBAE Q39146447-D860A698-9618-4E92-885B-6D03D5FBAD4C Q39301507-D3EEA2CB-A803-45E2-A033-51845641CA27 Q40872027-CDF4A00C-EA17-4473-B634-629301EE0FD3 Q42036645-AD730C53-6EE2-43A2-9794-BB89648A1081 Q42281478-429CCE1E-9A36-48BD-A167-636D0BA5A2C8 Q44190698-E592E02C-8170-4F3C-8BE8-78610D70F5B4 Q44800085-94C8442B-6167-4451-9C0D-2EADF67E6CD4 Q46297739-4ED91409-16A8-47E6-A906-047B77F18BED Q48062902-0454960D-A766-4CB9-A0F7-534A992CFC75 Q48474979-BD38B9A1-68B0-42FA-98EE-5D136F5DCE75 Q48557994-9F9465AE-5A74-4B26-B9C5-BC4706C08056 Q48691393-880A803B-F099-46EB-AA31-CB35A6981B20 Q50134122-4AC5C4FB-86A1-4B2B-AD09-4B59E1C12838 Q57480295-BA8794D6-1A8D-40A5-9D01-CF16D7E28EB0 Q58774884-9257A846-3DF9-4C6E-8076-CA9E704D7F2C

P2860

Apolipoproteins in the brain: implications for neurological and psychiatric disorders.

http://www.wikidata.org/entity/Q34680878

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

Apolipoproteins in the brain: implications for neurological and psychiatric disorders.

@ast

Apolipoproteins in the brain: implications for neurological and psychiatric disorders.

@en

Apolipoproteins in the brain: implications for neurological and psychiatric disorders.

@nl

type

label

Apolipoproteins in the brain: implications for neurological and psychiatric disorders.

@ast

Apolipoproteins in the brain: implications for neurological and psychiatric disorders.

@en

Apolipoproteins in the brain: implications for neurological and psychiatric disorders.

@nl

prefLabel

Apolipoproteins in the brain: implications for neurological and psychiatric disorders.

@ast

Apolipoproteins in the brain: implications for neurological and psychiatric disorders.

@en

Apolipoproteins in the brain: implications for neurological and psychiatric disorders.

@nl

P1433

Q34680878-F3A4DBAE-F82A-483E-8BBF-98BCD871781F

P1476

Q34680878-40305B62-D4C8-4C67-AB8F-F18E5210CFD9

P2093

Q34680878-6F3E6DCA-FD17-4BED-92BB-8501547FD704

Q34680878-BB027DE1-6907-4687-A009-A3B48E296349

Q34680878-E8C5A0A9-D8FF-4404-AD31-E93F36903FEB

P2860

Q34680878-00138352-949F-4023-91FA-95F175463154

Q34680878-01363A61-43A4-474F-9F13-A26B7A2035FE

Q34680878-01C43679-C7AA-4DD5-BA6C-A61445B49801

Q34680878-06D9DA54-FF13-454A-8B22-1BBCE09A38E6

Q34680878-085D8AC2-48FF-47F0-8762-4369268BBE08

Q34680878-09979059-177F-436F-9DBF-407ED32CC232

Q34680878-0D342720-9EDF-4C12-A62F-5C8ECF3A8FBA

Q34680878-0D833741-6F4D-474E-B231-C62F71CF9A47

Q34680878-0F4084E1-8101-42F0-83EB-0C5F7ED1E333

Q34680878-106A1C3B-100B-4B66-931A-C9DEE0D3E69A

P304

Q34680878-51D3B18C-9E31-47A7-A3DD-F188DD8808BE

P31

Q34680878-A652532E-A29A-4259-A4C0-4EC6BC9526CF

P356

Q34680878-64614865-F0A4-47D3-9CC1-9B51495A18E1

P433

Q34680878-E6CA3144-A20F-4EEA-B7B7-7DF238C408CA

P478

Q34680878-7FC4559F-E92D-4BF3-A0C7-E6A22EE9C2D5

P577

Q34680878-A00F414C-35FC-4704-AA86-9BDB690DFB05

P698

Q34680878-2CEDBBB2-A5EB-4683-BD5A-00F66FDD0EA3

P932

Q34680878-CE73E4F5-38DE-462F-871B-F50C139D5201

P356

P1433

Clinical Lipidology

P1476

Apolipoproteins in the brain: implications for neurological and psychiatric disorders.

@en

P2093

Brett Garner

http://www.w3.org/2001/XMLSchema#string

Cyndi Shannon Weickert

http://www.w3.org/2001/XMLSchema#string

David A Elliott

http://www.w3.org/2001/XMLSchema#string

P2860

The generation and function of soluble apoE receptors in the CNS

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

Apolipoprotein A-I directly interacts with amyloid precursor protein and inhibits A beta aggregation and toxicity

Plasma lipoproteins: apolipoprotein structure and function

Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease

Possible neuroprotective role of clusterin in Alzheimer's disease: a quantitative immunocytochemical study

Alpha-synuclein and polyunsaturated fatty acids promote clathrin-mediated endocytosis and synaptic vesicle recycling

Identification of glycoprotein 330 as an endocytic receptor for apolipoprotein J/clusterin

Neuroprotective effect of apolipoprotein D against human coronavirus OC43-induced encephalitis in mice

Apolipoprotein D is involved in the mechanisms regulating protection from oxidative stress

P304

555-573

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/CLP.10.37

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

51

http://www.w3.org/2001/XMLSchema#string

P577

2010-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21423873

http://www.w3.org/2001/XMLSchema#string

P932

3058497

http://www.w3.org/2001/XMLSchema#string